These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 14492395)
1. Symposium on clinical drug evaluation and human pharmacology. XII. Assessment of antianginal agents. RINZLER SH Clin Pharmacol Ther; 1962; 3():505-9. PubMed ID: 14492395 [No Abstract] [Full Text] [Related]
2. Clinical pharmacology of antianginal drugs. MODELL W Clin Pharmacol Ther; 1962; 3():97-108. PubMed ID: 14474953 [No Abstract] [Full Text] [Related]
3. Assay of antianginal agents; the rapport period. COLE SL; KAYE H; GRIFFITH GC J Am Med Assoc; 1958 Sep; 168(3):275-7. PubMed ID: 13575155 [No Abstract] [Full Text] [Related]
4. [The treatment of angina pectoris: clinical and instrumental evaluation of an anti-anginal drug combination]. MALFANTI PL Minerva Med; 1960 Oct; 51():3578-85. PubMed ID: 13765767 [No Abstract] [Full Text] [Related]
5. EXPERIMENTAL APPROACHES TO THE DEVELOPMENT OF ANTIANGINAL DRUGS. WINBURY MM Adv Pharmacol (1962); 1964; 3():1-82. PubMed ID: 14236560 [No Abstract] [Full Text] [Related]
6. Evaluation of drug therapy of angina pectoris. PORDY L; CHESKY K Trans Am Coll Cardiol; 1952; 2():128. PubMed ID: 13049502 [No Abstract] [Full Text] [Related]
7. [Evaluation of antianginal effects of running pulse magnetic field and drug therapy on the physical working capacity and hemodynamics in patients with stable angina pectoris]. Orlov LL; Makoeva LD; Glezer MG; Titov SIu; Arzhanenko OM; Margarian AG; Musev VA; Memetov KA; Belinskaia TF Kardiologiia; 1992 Feb; 32(2):23-6. PubMed ID: 1527930 [TBL] [Abstract][Full Text] [Related]
8. Therapy of angina pectoris: evaluation of anti-anginal agents and procedures. COLE SL Dis Chest; 1958 Sep; 34(3):330-4. PubMed ID: 13574042 [No Abstract] [Full Text] [Related]
9. An investigation of the pharmacological treatment of angina pectoris. GANZ V; FRONEK A; HAMMER J Rev Czech Med; 1962; 8():137-42. PubMed ID: 13896706 [No Abstract] [Full Text] [Related]
14. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease. Bonetti PO; Kaiser C; Zellweger MJ; Grize L; Erne P; Schoenenberger RA; Pfisterer ME; J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):29-37. PubMed ID: 15821836 [TBL] [Abstract][Full Text] [Related]
15. [The efficacy of basic antianginal preparations in patients with stenocardia after the aortocoronary bypass operation]. Vykhovaniuk IV Ter Arkh; 1991; 63(8):41-5. PubMed ID: 1792615 [TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of antianginal preparations in ischemic heart disease depending on the duration of the courses of treatment]. Progonnaia VV Vrach Delo; 1988 Jul; (7):29-31. PubMed ID: 3188458 [No Abstract] [Full Text] [Related]
17. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study. Fanaroff AC; Kaltenbach LA; Peterson ED; Hess CN; Cohen DJ; Fonarow GC; Wang TY J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051217 [TBL] [Abstract][Full Text] [Related]
18. Experimental and early investigational drugs for angina pectoris. Elgendy IY; Winchester DE; Pepine CJ Expert Opin Investig Drugs; 2016 Dec; 25(12):1413-1421. PubMed ID: 27791405 [TBL] [Abstract][Full Text] [Related]
19. [Evidence-based optimal treatment strategy of patients with angina pectoris]. Jánosi A Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559 [TBL] [Abstract][Full Text] [Related]